NicOx: Clinical Trials

15 trials sponsored by NicOx, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 1 withdrawn. 6 Phase 1, 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 33Completed 3
Phase 21Withdrawn 1

Follow NicOx: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Iota-Carrageenan, Carmellose - Adenoviral Conjunctivitis
Phase 2WithdrawnNicOx2017-01-012017-05-10
ADenoVirus Initiative Study in Epidemiology in UK
Viral Conjunctivitis
CompletedNicOx312015-02-012015-10-20
ADenoVirus Initiative Study in Epidemiology in Italy
Viral Conjunctivitis
CompletedNicOx2412014-11-012017-02-16
ADenoVirus Initiative Study in Epidemiology in Spain
Viral Conjunctivitis
CompletedNicOx3862014-07-012017-01-10
ADenoVirus Initiative Study in Epidemiology in Germany
Viral Conjunctivitis
CompletedNicOx2402014-04-012017-01-11
ADenoVirus Initiative Study in Epidemiology in France
Viral Conjunctivitis
CompletedNicOx3572013-06-012015-02-10
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male
naproxcinod 750 bid, naproxcinod 3000 mg od, naproxen 500 mg bid - Pharmacokinetics
Phase 1CompletedNicOx242010-01-012011-08-11
Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide
naproxcinod, Naproxen, placebo - Renal Hemodynamics
Phase 1CompletedNicOx312009-01-012011-06-17
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
naproxcinod - Renal Failure
Phase 1CompletedNicOx322008-05-012009-01-28
A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure
naproxcinod 375 mg -750 mg -1125 mg bid, naproxen 250 mg - 500mg -750 mg bid - Osteoarthritis, Hypertension
Phase 1CompletedNicOx1202008-03-012011-06-17
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
naproxcinod 375 mg bid, naproxcinod 750 mg bid, naproxen 250 mg bid - Osteoarthritis, Hypertension
Phase 1CompletedNicOx3002008-03-012011-06-17
A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
naproxcinod - Liver Disease
Phase 1CompletedNicOx242008-01-012011-06-17
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Naproxcinod, Naproxen, Placebo - Osteoarthritis, Osteoarthritis, Hip
Phase 3CompletedNicOx8002007-06-012009-02-20
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
Naproxcinod 375 mg bid, Naproxcinod 750 mg bid, Naproxen 500 mg bid - Osteoarthritis
Phase 3CompletedNicOx10202007-04-012011-06-17
Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
Placebo, Naproxcinod 375 mg, Naproxen - Osteoarthritis
Phase 3CompletedNicOx9182005-12-012011-06-17

Conditions studied

Conjunctivitis, Viral (5)  ·  Osteoarthritis (5)  ·  Hypertension (2)  ·  Arthritis (1)  ·  Liver Diseases (1)  ·  Osteoarthritis, Hip (1)  ·  Renal Insufficiency (1)

Interventions

naproxen-n-butyl nitrate (9)  ·  Naproxen (7)  ·  BID protein, human (3)  ·  Carboxymethylcellulose Sodium (1)  ·  Carrageenan (1)  ·  Furosemide (1)  ·  Ibuprofen (1)

Countries

United States (6)  ·  Spain (2)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Antonio Rusca, MD FMH (1)  ·  Brigitte Duquesroix (1)  ·  Elizabeth M Messmer, MD (1)  ·  Eric Tuil (1)  ·  Paolo Fogagnolo, MD (1)  ·  Rakesh Jayaswal (1)

Results publications

PMID 20202489, PMID 20722026